Page last updated: 2024-08-23

paclitaxel and Leukemia, Pre-B-Cell

paclitaxel has been researched along with Leukemia, Pre-B-Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cunningham, T; Müller, F; Pastan, I; Stookey, S1
Bhalla, K; Bullock, G; Huang, Y; Mahoney, ME; Miyashita, T; Ponnathpur, V; Ray, S; Reed, JC; Tang, C; Willingham, MC1

Other Studies

2 other study(ies) available for paclitaxel and Leukemia, Pre-B-Cell

ArticleYear
Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies.
    Oncotarget, 2017, May-09, Volume: 8, Issue:19

    Topics: Animals; Antineoplastic Agents; Bacterial Toxins; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Exotoxins; Humans; Immunotoxins; Mice; Paclitaxel; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Sialic Acid Binding Ig-like Lectin 2; Treatment Outcome; Xenograft Model Antitumor Assays

2017
High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.
    Leukemia, 1994, Volume: 8, Issue:11

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; DNA Damage; DNA, Neoplasm; In Vitro Techniques; Microtubules; Paclitaxel; Phosphoproteins; Phosphotyrosine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tubulin; Tumor Cells, Cultured; Tyrosine

1994